TCT-825 Outcomes of Patients With and Without Hyperlipidemia Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis from the EXCEL Trial

Authors :: Shmuel Chen
Yangbo Liu
Mathias Vrolix
A. Pieter Kappetein
Ori Ben-Yehuda
Björn Redfors
Carlos Macaya
Gregg W. Stone
Joseph F. Sabik
Patrick W. Serruys
Source :: Journal of the American College of Cardiology. 70:B335
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.
Abstract: Hyperlipidemia (HPL) is an important risk factor for atherosclerotic disease, and treatment with statins has been shown to reduce this risk; however, there is paucity of data regarding the effect of treated HPL in pts undergoing revascularization for left main coronary artery disease (LMCAD). The

Subjects :: medicine.medical_specialty
business.industry
medicine.medical_treatment
Atherosclerotic disease
nutritional and metabolic diseases
Revascularization
medicine.disease
Internal medicine
Hyperlipidemia
medicine
Cardiology
Left main coronary artery disease
Risk factor
Cardiology and Cardiovascular Medicine
business

Full Text Access

Tools